Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 16NIH 3NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia 8Neuroblastoma 7Leukemia, Myeloid, Acute 6Sarcoma 5Leukemia, Myelomonocytic, Acute 5Leukemia, Monocytic, Acute 5Leukemia, Megakaryoblastic, Acute 5Leukemia, Erythroblastic, Acute 5Rhabdomyosarcoma 3Malignant mesenchymal tumor 3Multiple Myeloma 2Ganglioneuroblastoma 2Congenital Abnormalities 2Brain Neoplasms 2Stomach Neoplasms 1Radiation Injuries 1Prostatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Oropharyngeal Neoplasms 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Myelodysplastic Syndromes 1Mouth Neoplasms 1Melanoma 1Medulloblastoma 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1

Interventions

Radiotherapy 4Vincristine 3Rituximab 3Prednisone 3Etoposide 3Cyclophosphamide 3Methotrexate 2Immunohistochemistry 2Doxorubicin 2Cytarabine 2Cisplatin 2sargramostim 1pegfilgrastim 1merphos 1liposomal amphotericin B 1ixabepilone 1ibritumomab tiuxetan 1Whole-Body Irradiation 1Watchful Waiting 1Vancomycin 1VAP-cyclo protocol 1Tazobactam 1Radioimmunotherapy 1Polymerase Chain Reaction 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Photopheresis 1Peripheral Blood Stem Cell Transplantation 1Pentostatin 1Palliative Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, Large-Cell, Immunoblastic × sargramostim × Clear all
NCT00389818 2018-06-06

Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's Lymphoma

AIDS Malignancy Consortium

Phase 2 Completed
43 enrolled 7 charts
Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡